Stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer: toxicity profile and early oncologic outcomes.

Radiat Oncol · 2019 · PMC6679492 · PMID 31375119

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

These data suggest that there may be significant potential for further toxicity reduction using the spacer for larger SBRT volumes and higher doses currently being evaluated for high risk prostate cancer.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.